JIC
BMRA icon

Johnson Investment Counsel’s Biomerica BMRA Stock Holding History

Johnson Investment Counsel’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,263
Closed -$8.4K – 769
2024
Q1 		$8.4K Buy
+1,263
New +$10.3K ﹤0.01% 760

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Johnson Investment Counsel's BMRA Position: Q2 2024 in Review

Johnson Investment Counsel sold out of Biomerica (BMRA) in Q2 2024, closing a stake of 1,263 shares — an estimated $8.4K sold.

Johnson Investment Counsel first reported a position in BMRA in Q1 2024 and held it in 1 quarter. The position peaked at $8.4K in Q1 2024. 35 funds tracked by Wall St. Rank hold BMRA as of Q2 2024.

  • Johnson Investment Counsel reported no remaining Biomerica position as of Q2 2024 after selling out during the quarter.
  • Johnson Investment Counsel sold 1,263 Biomerica shares in Q2 2024, an estimated $8.4K.
  • Johnson Investment Counsel first reported a position in Biomerica in Q1 2024 and held it in 1 quarter.
  • Johnson Investment Counsel's Biomerica position peaked at $8.4K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Biomerica as of Q2 2024.

Based on Johnson Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.